ARS Pharmaceuticals (SPRY) Stock Chart & Stock Price History → Are you prepared for a financial lockdown? (From Weiss Ratings) (Ad) Free SPRY Stock Alerts $8.50 -0.16 (-1.85%) (As of 02:07 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ARS Pharmaceuticals Stock Price Performance5 Day Performance-7.80%1 Month Performance-7.09%3 Month Performance-8.41%6 Month Performance+61.04%Year-To-Date Performance+53.10%1 Year Performance+34.89% Receive SPRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsAre you prepared for a financial lockdown?A new kind of American dystopia is being built before our eyes, and most people have no idea what's happening. That's why I've recorded this urgent message to give you all the details on how to prepare … Including three steps to take right now.Click here to watch my video before it's too late. SPRY Stock Chart for Monday, June, 17, 2024 SPRY Chart by TradingView ARS Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/14/2024$8.94$8.66-3.13%$8.98$8.60461,261 shs$839.07 million06/13/2024$9.10$8.94-1.76%$9.23$8.80331,797 shs$866.20 million06/12/2024$8.97$9.10+1.45%$9.37$9.00607,406 shs$881.70 million06/11/2024$9.07$8.97-1.10%$9.02$8.84315,606 shs$869.10 million06/10/2024$8.81$9.07+2.95%$9.11$8.70368,895 shs$878.84 million06/07/2024$8.82$8.81-0.11%$8.90$8.68308,661 shs$853.60 million Get the Latest News and Ratings for SPRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/06/2024$9.11$8.82-3.18%$9.15$8.80390,674 shs$854.57 million06/05/2024$8.94$9.11+1.90%$9.19$8.85371,564 shs$882.67 million06/04/2024$9.04$8.94-1.11%$9.19$8.92364,690 shs$866.20 million06/03/2024$8.88$9.04+1.80%$9.25$8.77531,661 shs$875.89 million05/31/2024$8.91$8.88-0.34%$9.30$8.85604,346 shs$860.38 million05/30/2024$8.82$8.91+1.02%$9.02$8.82330,119 shs$863.29 million05/29/2024$8.98$8.82-1.78%$8.99$8.80324,022 shs$854.57 million05/28/2024$8.98$8.98$9.23$8.77613,784 shs$870.07 million05/27/2024$8.98$8.98$9.14$8.76279,100 shs$870.07 million05/24/2024$8.80$8.98+2.05%$9.14$8.76279,138 shs$870.07 million05/23/2024$8.93$8.80-1.46%$9.09$8.73276,297 shs$852.63 million05/22/2024$8.83$8.93+1.13%$9.05$8.82230,171 shs$865.27 million05/21/2024$9.19$8.83-3.92%$9.15$8.81264,869 shs$855.54 million05/20/2024$9.03$9.19+1.77%$9.31$9.08309,942 shs$890.42 million05/17/2024$9.10$9.03-0.77%$9.25$8.99290,875 shs$874.92 million05/16/2024$8.88$9.10+2.48%$9.14$8.79404,491 shs$881.70 million05/15/2024$8.98$8.88-1.11%$9.16$8.83301,222 shs$860.38 million05/14/2024$8.89$8.98+1.01%$9.06$8.88357,043 shs$870.07 million05/13/2024$8.74$8.89+1.72%$9.02$8.72322,331 shs$861.35 million05/10/2024$8.80$8.74-0.68%$9.00$8.59306,001 shs$846.85 million05/09/2024$9.06$8.80-2.87%$9.19$8.72332,056 shs$852.67 million05/08/2024$9.47$9.06-4.33%$9.55$8.98352,386 shs$877.86 million05/07/2024$9.45$9.47+0.21%$9.51$9.14474,003 shs$917.55 million05/06/2024$9.75$9.45-3.08%$9.80$9.10401,245 shs$915.61 million05/03/2024$9.46$9.75+3.07%$9.76$9.39364,083 shs$944.68 million05/02/2024$9.33$9.46+1.39%$9.51$8.94575,500 shs$916.58 million05/01/2024$8.70$9.33+7.24%$9.62$8.721.11 million shs$903.98 million04/30/2024$8.60$8.70+1.16%$8.79$8.51335,331 shs$839.55 million04/29/2024$8.35$8.60+2.99%$8.72$8.41364,643 shs$829.90 million04/26/2024$8.09$8.35+3.21%$8.66$8.10520,296 shs$805.78 million04/25/2024$8.26$8.09-2.06%$8.18$7.67534,599 shs$780.69 million04/24/2024$8.50$8.26-2.82%$8.55$8.16334,673 shs$797.09 million04/23/2024$8.21$8.50+3.53%$8.83$8.31510,339 shs$820.27 million04/22/2024$8.47$8.21-3.07%$8.60$8.15394,545 shs$792.27 millionAre you prepared for a financial lockdown? (Ad)A new kind of American dystopia is being built before our eyes, and most people have no idea what's happening. That's why I've recorded this urgent message to give you all the details on how to prepare … Including three steps to take right now.Click here to watch my video before it's too late.04/19/2024$8.44$8.47+0.36%$8.65$8.25487,833 shs$817.36 million04/18/2024$9.06$8.44-6.84%$9.19$8.38914,750 shs$814.46 million04/17/2024$9.18$9.06-1.31%$9.28$8.88456,562 shs$874.29 million04/16/2024$9.24$9.18-0.65%$9.46$9.05477,152 shs$885.87 million04/15/2024$9.02$9.24+2.44%$9.30$8.95459,613 shs$891.66 million04/12/2024$9.24$9.02-2.38%$9.24$8.93689,994 shs$870.43 million04/11/2024$9.27$9.24-0.32%$9.44$9.17442,524 shs$891.66 million04/10/2024$9.33$9.27-0.64%$9.42$9.03390,698 shs$894.56 million04/09/2024$9.93$9.33-6.04%$9.99$9.13801,097 shs$900.36 million04/08/2024$9.87$9.93+0.61%$10.10$9.65476,496 shs$958.25 million04/05/2024$9.53$9.87+3.57%$10.00$9.43442,943 shs$952.46 million04/04/2024$9.40$9.53+1.38%$9.70$9.35633,572 shs$919.66 million04/03/2024$9.28$9.40+1.29%$9.69$9.21551,467 shs$907.10 million04/02/2024$9.47$9.28-2.01%$9.62$9.27510,665 shs$895.52 million04/01/2024$10.22$9.47-7.34%$10.20$9.41722,938 shs$913.86 million03/29/2024$10.22$10.22$11.27$10.161.65 million shs$986.25 million03/28/2024$9.96$10.22+2.61%$11.27$10.161.64 million shs$986.23 million03/27/2024$10.00$9.96-0.40%$10.20$9.651.18 million shs$961.14 million03/26/2024$9.13$10.00+9.53%$10.15$9.182.38 million shs$965 million03/25/2024$8.65$9.13+5.55%$9.39$8.661.29 million shs$881.05 million03/22/2024$9.00$8.65-3.89%$9.10$8.56769,084 shs$830.40 million03/21/2024$8.70$9.00+3.45%$9.00$8.70731,418 shs$864 million03/20/2024$8.46$8.70+2.84%$8.85$8.41627,032 shs$835.20 million03/19/2024$9.12$8.46-7.24%$9.08$8.401.15 million shs$812.16 million03/18/2024$9.16$9.12-0.44%$9.39$8.951.16 million shs$875.52 million Related Companies: RARE Stock Chart CORT Stock Chart AXSM Stock Chart MRUS Stock Chart PBH Stock Chart HCM Stock Chart FOLD Stock Chart ARWR Stock Chart BHVN Stock Chart GERN Stock Chart Receive SPRY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SPRY) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.